VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178 | -29.6% | 23,025 | +4.1% | 0.00% | – |
| Q2 2023 | $253 | +178.0% | 22,126 | +86.5% | 0.00% | – |
| Q1 2023 | $91 | +85.7% | 11,866 | +46.7% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 8,091 | -21.3% | 0.00% | – |
| Q3 2022 | $60,000 | 0.0% | 10,283 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -55.2% | 10,283 | -41.8% | 0.00% | – |
| Q1 2022 | $134,000 | +605.3% | 17,678 | +144.7% | 0.00% | – |
| Q4 2021 | $19,000 | +26.7% | 7,223 | +21.0% | 0.00% | – |
| Q3 2021 | $15,000 | -58.3% | 5,970 | -33.2% | 0.00% | – |
| Q2 2021 | $36,000 | – | 8,940 | +4922.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 178 | -98.5% | 0.00% | – |
| Q4 2020 | $86,000 | +473.3% | 12,102 | +1225.5% | 0.00% | – |
| Q3 2019 | $15,000 | -96.9% | 913 | -96.4% | 0.00% | -100.0% |
| Q1 2018 | $482,000 | +44.3% | 25,658 | +27.2% | 0.00% | 0.0% |
| Q4 2017 | $334,000 | – | 20,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |